Stocks and Investing Stocks and Investing
Fri, February 10, 2023

Navin Jacob Maintained (ABBV) at Hold with Increased Target to $152 on, Feb 10th, 2023


Published on 2024-10-28 01:33:05 - WOPRAI, Navin Jacob
  Print publication without navigation


Navin Jacob of UBS, Maintained "AbbVie Inc." (ABBV) at Hold with Increased Target from $150 to $152 on, Feb 10th, 2023.

Navin has made no other calls on ABBV in the last 4 months.



There are 9 other peers that have a rating on ABBV. Out of the 9 peers that are also analyzing ABBV, 4 agree with Navin's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Geoff Meacham of "B of A Securities" Maintained at Hold with Increased Target to $165 on, Wednesday, December 14th, 2022
  • Navaan Ty of "Exane BNP Paribas" Initiated at Hold and Held Target at $169 on, Thursday, December 8th, 2022
  • Justin Smith of "Societe Generale" Downgraded from Strong Buy to Hold on, Tuesday, November 8th, 2022
  • Carter Gould of "Barclays" Maintained at Hold with Decreased Target to $155 on, Monday, October 31st, 2022


These are the ratings of the 5 analyists that currently disagree with Navin


  • Gavin Clark-Gartner of "Evercore ISI Group" Maintained at Buy with Increased Target to $165 on, Thursday, February 9th, 2023
  • Robyn Karnauskas of "Truist Securities" Reiterated at Strong Buy and Held Target at $180 on, Thursday, February 9th, 2023
  • Gary Nachman of "BMO Capital" Maintained at Buy with Decreased Target to $167 on, Monday, February 6th, 2023
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $182 on, Tuesday, December 6th, 2022
  • Trung Huynh of "Credit Suisse" Initiated at Buy and Held Target at $170 on, Friday, November 18th, 2022
Contributing Sources